Thiocolchicoside

Phase 3Small molecule

Sanofi

Thiocolchicoside is one of 54 small molecule programs targeting Low back pain. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Low Back PainActive, not recruiting

MyalgiaActive, not recruiting

Low Back PainPhase 3

Active, not recruiting

MyalgiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

237 competitors in Low Back Pain

#DrugCompanyPhaseTrials

Arcoxia

Novartis

Phase 3

1 2

Suboxone

IIndivior Inc.

Phase 3

4 3

Tylenol

KKenvue Brands

Phase 3

3 4

Anjeso

Boehringer Ingelheim

Phase 3

1 5

Tanezumab

Pfizer

Phase 3

4 6

Xylocaine

MMEDRx USA, Inc.

Phase 3

1 7

Amoxil

GGlobal Antibiotics Research and Development Partnership

Phase 3

1 8

Circadin

NNeurim Pharmaceuticals Ltd.

Phase 3

1 9

Hydrocodone/acetaminophen

AbbVie

Phase 3

2 10

Oxycodone CR

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Low back pain2 trials

Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain

Completed· Sanofi logo

Sanofi·Phase 4·NCT00917436·183 enrolled

Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain

Completed· Sanofi logo

Sanofi·Phase 3·NCT00679146·334 enrolled

Efficacy1 trial

EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes

Completed· Sanofi logo

Sanofi·Phase 4·NCT00272532·65 enrolled

Myalgia1 trial

Evaluation of the Effects of Treatments Applied to Patients With Facial Myalgia on Occlusion Parameters

Completed·YYuzuncu Yil University·N/A·NCT05261971·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Thiocolchicoside. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Thiocolchicoside compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Thiocolchicoside. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Sanofi

Thiocolchicoside

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Low back pain2 trials

Efficacy1 trial

Myalgia1 trial

References

Drug Info

Quick Facts

Related News